President Obama on Tuesday signed into law a bill aimed at encouraging pharmaceutical companies to help combat the Zika virus and develop vaccines.
The legislation puts the Zika virus--a mosquito-borne illness that is spreading throughout South and Central America--to the Food and Drug Administration's priority review voucher program in order to jump-start the development of treatments for tropical diseases.
After the 2015 taper-tantrum, markets have become more volatile. Looks like DJI is trendless, and the Naz and R2K seem in downtrends. My guess is for continued volatility until elections unless something rocks the boat.